Prone Flexed Position in Percutanous Nephrolithotomy
1 other identifier
interventional
300
1 country
1
Brief Summary
prone flexed position in percutanous nephrolithotomy in comparsion with standard prone position. A randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 12, 2020
CompletedFirst Posted
Study publicly available on registry
April 14, 2020
CompletedApril 15, 2020
April 1, 2020
2 years
April 12, 2020
April 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
position complications
Comparing the prone with the prone-flexed position for PCNL reporting complications using the Clavien-Dindo system
end of the study
Secondary Outcomes (4)
stone score system
end of the study
stone characteristics
end of the study
stone volume
end of the study
hemostatic measures
end of the study
Study Arms (2)
prone flexed
ACTIVE COMPARATORprone flexed PCNL position
prone
ACTIVE COMPARATORprone position PCNL
Interventions
different procedure positioning
Eligibility Criteria
You may qualify if:
- Large renal or upper ureteral calculi or both,
You may not qualify if:
- (1) Age \<18 years or Pregnancy (2) Ureter pelvic junction obstruction (3) Bilateral simultaneous PCNL (4) Need for 3 percutaneous tracts intraoperative (5) Morbid obesity (BMI \>40) (6) Non opaque renal stones. (7)Refuse to complete study requirements (8)Untreated UTI (9)Atypical bowel interposition by CT (10)Tumour in the presumptive access tract area or Potential malignant kidney tumour
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diaa Eldin Taha, MD
Lecturer of urology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of urology
Study Record Dates
First Submitted
April 12, 2020
First Posted
April 14, 2020
Study Start
April 1, 2018
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
April 15, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share